Visalytics
Visalytics
approved EB-2 (NIW)

Manager

Biotechnologies · India · 2023-02-14

Processing Time
27 days
Decision Date
2023-02-14
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research using biotechnological principles to analyze the interaction of viruses and drug therapies to improve public health. The work specifically focuses on developing novel methods to address major global diseases and remediate health concerns such as HIV and the Zika virus.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has broad implications for the U.S. by developing methods to address major health concerns like HIV and Zika virus.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned through a Ph.D., a strong publication and citation record, and 7 years of fruitful work in the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to public health and the recognition of his work by the NIH make it beneficial to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. and 7 years of experience, supported by 6 peer-reviewed journal articles and 136 citations. The evidence included 14 peer reviews, expert recommendation letters, and documentation of funding from the National Institutes of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 591 days 2025-11-27
The petitioner proposes to continue her research in biomedical science, specifically focusing on uncovering the mechanisms of disease-causing viruses and tuberculosis to identify how they operate and can be more effectively treated. Her work involves investigating viral mechanisms, immune responses, and therapeutic pathways to develop novel antiviral treatments and nonviral delivery platforms.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 28 days 2025-08-20
The petitioner proposes to continue her research into how HIV establishes viral reservoirs that allow it to persist despite treatment. She utilizes advanced single-molecule and live-cell imaging techniques to uncover molecular mechanisms sustaining viral transcription. Her work aims to identify strategies for developing a functional cure for HIV.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 27 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist